# Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

> **NCT00288743** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 30 (—)

## Conditions studied

- Critically Ill Patients

## Interventions

- **DRUG:** to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.

## Key facts

- **NCT ID:** NCT00288743
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288743, "Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00288743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*